Skip to main content

ADVERTISEMENT

Rocco Vergallo, MD, PhD

Hard Events AfteR Orsiro Sirolimus-Eluting Stent (HEROES) in STEMI: A Multicenter Registry
12/01/2020
Our objective was to evaluate the safety and efficacy of the Orsiro sirolimus-eluting stent (Biotronik) in patients with ST-segment elevation myocardial infarction undergoing primary PCI. Specific drug-eluting stent platforms might influence...
Our objective was to evaluate the safety and efficacy of the Orsiro sirolimus-eluting stent (Biotronik) in patients with ST-segment elevation myocardial infarction undergoing primary PCI. Specific drug-eluting stent platforms might influence...
Our objective was to evaluate...
12/01/2020
Journal of Invasive Cardiology
Original Contribution
11/01/2021
Dr. Mariani and colleagues retrospectively evaluated 70 plaques with PR at the FD-OCT (25 in stable CAD patients and 45 in NSTEMI patients). Main clinical, angiographic, and morphological features were compared.
Dr. Mariani and colleagues retrospectively evaluated 70 plaques with PR at the FD-OCT (25 in stable CAD patients and 45 in NSTEMI patients). Main clinical, angiographic, and morphological features were compared.
Dr. Mariani and colleagues...
11/01/2021
Journal of Invasive Cardiology